Author: digi

Periodic Review of Shipping Lanes, Routes and Packaging Standards Comprehensive Step-by-Step Guide to Periodic Review of Shipping Lanes, Routes, and Packaging Standards in Pharma Supply Chain Effective management of the pharmaceutical supply chain necessitates stringent adherence to Good Distribution Practice (GDP) principles, especially when evaluating shipping lanes, transit routes, and packaging standards. With increasing complexity…

Read More “Periodic Review of Shipping Lanes, Routes and Packaging Standards” »

Change Control for Supply Chains: When Route, Carrier or Packaging Changes Trigger Risk Comprehensive Change Control in Pharma Supply Chains: Managing Risks From Route, Carrier, and Packaging Changes In today’s pharmaceutical industry, maintaining strict quality and compliance is crucial across the entire supply chain. Changes related to distribution routes, carriers, or packaging can significantly impact…

Read More “Change Control for Supply Chains: When Route, Carrier or Packaging Changes Trigger Risk” »

GDP Audits: Planning, Execution and Evidence Packages GDP Audits: Comprehensive Step-by-Step Guide for Pharma Supply Chain Compliance Good Distribution Practice (GDP) audits represent a cornerstone activity for ensuring integrity, quality, and regulatory compliance within the pharma supply chain. This tutorial provides a systematic approach to planning, executing, and compiling evidence packages for GDP audits with…

Read More “GDP Audits: Planning, Execution and Evidence Packages” »

Reverse Logistics: Handling Recalls, Expired Goods and Damaged Shipments Comprehensive Step-by-Step Guide to Reverse Logistics in Pharma: Managing Recalls, Expired Goods, and Damaged Shipments The pharmaceutical industry relies on meticulous supply chain management to guarantee product quality, patient safety, and regulatory compliance. One critical but often overlooked aspect of pharma supply chain operations is reverse…

Read More “Reverse Logistics: Handling Recalls, Expired Goods and Damaged Shipments” »

Recall Readiness in Supply Chain: Traceability, Rapid Response and Mock Recalls Step-by-Step Tutorial on Recall Readiness in Pharmaceutical Supply Chain: Ensuring Traceability, Rapid Response, and Effective Mock Recalls Pharmaceutical companies operating under stringent Good Distribution Practices (GDP) requirements in the US, UK, and EU face the critical challenge of maintaining recall readiness in their supply…

Read More “Recall Readiness in Supply Chain: Traceability, Rapid Response and Mock Recalls” »

Designing a Global Recall Playbook: Timelines, Roles and Communication Flow Step-by-Step Guide to Designing a Global Recall Playbook: Effective Timelines, Roles, and Communication Flow Ensuring that pharmaceutical products are rapidly and effectively recalled when necessary is a critical component of Good Distribution Practice (GDP) compliance and overall pharmaceutical supply chain integrity. For companies operating globally,…

Read More “Designing a Global Recall Playbook: Timelines, Roles and Communication Flow” »

GDP Deviations: Identification, Investigation and Documentation Step-by-Step Guide to Managing GDP Deviations in Pharma Supply Chain and Cold Chain Processes Good Distribution Practice (GDP) is a critical component in maintaining the quality and integrity of medicinal products throughout the supply chain. In pharmaceutical distribution, warehousing, and cold chain logistics, deviations from established GDP standards can…

Read More “GDP Deviations: Identification, Investigation and Documentation” »

Creating an Investigation Framework for Supply Chain Temperature Failures Step-by-Step Tutorial: Creating an Investigation Framework for Supply Chain Temperature Failures Maintaining the integrity of pharmaceutical products during supply chain operations is a critical responsibility for companies operating within the US, UK, and EU markets. Temperature management, especially in cold chain logistics, plays a pivotal role…

Read More “Creating an Investigation Framework for Supply Chain Temperature Failures” »

Chain of Custody Requirements for High-Risk and Temperature-Sensitive Products Implementing Chain of Custody Requirements for High-Risk and Temperature-Sensitive Pharma Products Maintaining a secure, compliant, and robust chain of custody is essential when managing high-risk and temperature-sensitive pharmaceutical products throughout the pharma supply chain. Ensuring product integrity demands strict adherence to Good Distribution Practice (GDP) regulations…

Read More “Chain of Custody Requirements for High-Risk and Temperature-Sensitive Products” »

GDP for Clinical Trial Supplies: Packaging, Labelling and Shipment Controls Good Distribution Practice (GDP) for Clinical Trial Supplies: Packaging, Labelling, and Shipment Controls Effective control of clinical trial supplies is critical to ensuring the integrity, safety, and efficacy of investigational medicinal products (IMPs) throughout the pharmaceutical supply chain. Good Distribution Practice (GDP) requirements harmonize regulations…

Read More “GDP for Clinical Trial Supplies: Packaging, Labelling and Shipment Controls” »